BDBM50380671 CHEMBL2017275

SMILES: COc1cc2c(Nc3ccccc3CCN3CCOCC3)c(cnc2cc1-c1c(C)noc1C)C(N)=O

InChI Key: InChIKey=ZMSXXNUUWMPXGF-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50380671   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cytochrome P450 3A4 (Homo sapiens (Human))	BDBM50380671 (CHEMBL2017275) Show SMILES COc1cc2c(Nc3ccccc3CCN3CCOCC3)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(-7.39,1.64,;-7.39,.1,;-6.05,-.67,;-4.72,.1,;-3.39,-.66,;-2.06,.11,;-2.07,1.65,;-3.41,2.41,;-4.72,1.63,;-6.06,2.39,;-6.07,3.94,;-4.74,4.71,;-3.41,3.95,;-2.07,4.72,;-.74,3.96,;.59,4.73,;1.93,3.95,;3.26,4.72,;3.27,6.26,;1.93,7.03,;.59,6.26,;-.73,-.65,;-.72,-2.2,;-2.05,-2.97,;-3.39,-2.21,;-4.72,-2.98,;-6.06,-2.21,;-7.39,-2.98,;-7.42,-4.52,;-6.2,-5.46,;-8.9,-4.97,;-9.78,-3.71,;-8.85,-2.48,;-9.29,-1.01,;.6,.13,;1.94,-.63,;.59,1.67,)| Show InChI InChI=1S/C28H31N5O4/c1-17-26(18(2)37-32-17)21-14-24-20(15-25(21)35-3)27(22(16-30-24)28(29)34)31-23-7-5-4-6-19(23)8-9-33-10-12-36-13-11-33/h4-7,14-16H,8-13H2,1-3H3,(H2,29,34)(H,30,31)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.90E+3	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Inhibition of CYP3A4				Bioorg Med Chem Lett 22: 2963-7 (2012) Article DOI: 10.1016/j.bmcl.2012.01.125 BindingDB Entry DOI: 10.7270/Q2ZC83VK
					More data for this Ligand-Target Pair
Cytochrome P450 2C9 (Homo sapiens (Human))	BDBM50380671 (CHEMBL2017275) Show SMILES COc1cc2c(Nc3ccccc3CCN3CCOCC3)c(cnc2cc1-c1c(C)noc1C)C(N)=O |(-7.39,1.64,;-7.39,.1,;-6.05,-.67,;-4.72,.1,;-3.39,-.66,;-2.06,.11,;-2.07,1.65,;-3.41,2.41,;-4.72,1.63,;-6.06,2.39,;-6.07,3.94,;-4.74,4.71,;-3.41,3.95,;-2.07,4.72,;-.74,3.96,;.59,4.73,;1.93,3.95,;3.26,4.72,;3.27,6.26,;1.93,7.03,;.59,6.26,;-.73,-.65,;-.72,-2.2,;-2.05,-2.97,;-3.39,-2.21,;-4.72,-2.98,;-6.06,-2.21,;-7.39,-2.98,;-7.42,-4.52,;-6.2,-5.46,;-8.9,-4.97,;-9.78,-3.71,;-8.85,-2.48,;-9.29,-1.01,;.6,.13,;1.94,-.63,;.59,1.67,)| Show InChI InChI=1S/C28H31N5O4/c1-17-26(18(2)37-32-17)21-14-24-20(15-25(21)35-3)27(22(16-30-24)28(29)34)31-23-7-5-4-6-19(23)8-9-33-10-12-36-13-11-33/h4-7,14-16H,8-13H2,1-3H3,(H2,29,34)(H,30,31)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	2.20E+3	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Inhibition of CYP2C9				Bioorg Med Chem Lett 22: 2963-7 (2012) Article DOI: 10.1016/j.bmcl.2012.01.125 BindingDB Entry DOI: 10.7270/Q2ZC83VK
					More data for this Ligand-Target Pair